Vol , Issue Date of Publication: July 22, 2014
DOI: https://doi.org/10.20529/IJME.2014.045

, PDF Downloads:

Response to article titled “US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns” by Eric J Suba

Rengaswamy Sankaranarayanan
Bhagwan M Nene
Surendra Shastri
Pullikotil Ekkuru Esmy
Rajamanickam Rajkumar
Richard Muwonge
Rajaraman Swaminathan
Sylla G Malvi
Shubada Kane
Sangeeta Desai
Rohini Kelkar
Sanjay Hingmire
Kasturi Jayant
Dr Eric Suba has been distorting facts and persistently disseminating biased and misleading views and statements regarding our studies over the past several years. His article in the Indian Journal of Medical Ethics fails to mention the facts that seem unfavourable to his arguments, and the ethical concerns are unsubstantiated by the evidence. In this context, we present the following clarifications for the attention of your readers, notably with regard to: (i) the study design and inclusion of a control group; (ii) the informed consent of the women participating in the study; (iii) the conformity with international ethical standards and guidelines, and (iv) the provision of screening to women in the control arm of the studies. We also highlight the benefits that are flowing from this research and the risk that misinformation may further delay access for women to life-saving cervical cancer screening.

Copyright and license
©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0),
which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.

Full Text

Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation